Panagora Asset Management’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $414K | Sell |
20,334
-119
| -0.6% | -$2.42K | ﹤0.01% | 846 |
|
2025
Q1 | $371K | Sell |
20,453
-95,180
| -82% | -$1.73M | ﹤0.01% | 884 |
|
2024
Q4 | $2.92M | Sell |
115,633
-1,041
| -0.9% | -$26.3K | 0.01% | 440 |
|
2024
Q3 | $3.97M | Sell |
116,674
-1,673
| -1% | -$56.9K | 0.02% | 387 |
|
2024
Q2 | $4.38M | Buy |
+118,347
| New | +$4.38M | 0.02% | 336 |
|
2021
Q3 | – | Sell |
-1,150
| Closed | -$38K | – | 1841 |
|
2021
Q2 | $38K | Sell |
1,150
-343
| -23% | -$11.3K | ﹤0.01% | 2099 |
|
2021
Q1 | $31K | Hold |
1,493
| – | – | ﹤0.01% | 2255 |
|
2020
Q4 | $26K | Sell |
1,493
-281
| -16% | -$4.89K | ﹤0.01% | 2153 |
|
2020
Q3 | $26K | Hold |
1,774
| – | – | ﹤0.01% | 2144 |
|
2020
Q2 | $23K | Hold |
1,774
| – | – | ﹤0.01% | 2113 |
|
2020
Q1 | $3K | Hold |
1,774
| – | – | ﹤0.01% | 2342 |
|
2019
Q4 | $4K | Hold |
1,774
| – | – | ﹤0.01% | 2274 |
|
2019
Q3 | $4K | Buy |
1,774
+101
| +6% | +$228 | ﹤0.01% | 2309 |
|
2019
Q2 | $4K | Sell |
1,673
-5,017
| -75% | -$12K | ﹤0.01% | 2484 |
|
2019
Q1 | $33K | Hold |
6,690
| – | – | ﹤0.01% | 2146 |
|
2018
Q4 | $20K | Buy |
6,690
+2,044
| +44% | +$6.11K | ﹤0.01% | 2218 |
|
2018
Q3 | $31K | Buy |
4,646
+4,184
| +906% | +$27.9K | ﹤0.01% | 2134 |
|
2018
Q2 | $3K | Sell |
462
-95,094
| -100% | -$617K | ﹤0.01% | 2326 |
|
2018
Q1 | $3.34M | Buy |
95,556
+29,959
| +46% | +$1.05M | 0.01% | 679 |
|
2017
Q4 | $2.79M | Buy |
+65,597
| New | +$2.79M | 0.01% | 739 |
|
2015
Q3 | – | Sell |
-259
| Closed | -$98K | – | 2330 |
|
2015
Q2 | $98K | Sell |
259
-310
| -54% | -$117K | ﹤0.01% | 1951 |
|
2015
Q1 | $238K | Sell |
569
-1,230
| -68% | -$514K | ﹤0.01% | 1609 |
|
2014
Q4 | $492K | Buy |
1,799
+1,673
| +1,328% | +$458K | ﹤0.01% | 1289 |
|
2014
Q3 | $24K | Sell |
126
-46
| -27% | -$8.76K | ﹤0.01% | 2132 |
|
2014
Q2 | $42K | Sell |
172
-634
| -79% | -$155K | ﹤0.01% | 2129 |
|
2014
Q1 | $214K | Buy |
806
+760
| +1,652% | +$202K | ﹤0.01% | 1712 |
|
2013
Q4 | $17K | Buy |
+46
| New | +$17K | ﹤0.01% | 2107 |
|